$QS
QuantumScape Corp

2021 Q2 Form 10-Q Financial Statement

#000156459021039145 Filed on July 29, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2 2020 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $13.85M $62.86K
YoY Change 21926.73%
% of Gross Profit
Research & Development $35.78M $12.05M $13.35M
YoY Change 196.92%
% of Gross Profit
Depreciation & Amortization $3.520M $1.442M
YoY Change
% of Gross Profit
Operating Expenses $49.62M $14.23M $15.92M
YoY Change 248.79%
Operating Profit -$49.62M -$14.23M -$15.92M
YoY Change 248.79%
Interest Expense $238.0K
YoY Change
% of Operating Profit
Other Income/Expense, Net $130.6M $281.0K $538.0K
YoY Change 46380.43%
Pretax Income $80.99M -$62.86K
YoY Change -128938.69%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings $80.99M -$13.95M -$15.37M
YoY Change -680.77%
Net Earnings / Revenue
Basic Earnings Per Share $0.20 -$0.06
Diluted Earnings Per Share -$0.12 -$0.06
COMMON SHARES
Basic Shares Outstanding 405.0M 239.8M
Diluted Shares Outstanding 410.4M 239.8M

Balance Sheet

Concept 2021 Q2 2020 Q2 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $496.9M $1.700M
YoY Change 29128.88%
Cash & Equivalents $402.4M $29.18M $41.19M
Short-Term Investments $94.50M
Other Short-Term Assets $10.62M $200.0K
YoY Change 5211.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $1.578B $2.000M
YoY Change 78807.6%
LONG-TERM ASSETS
Property, Plant & Equipment $91.22M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $12.22M $230.0M
YoY Change -94.69%
Total Long-Term Assets $164.9M $230.0M
YoY Change -28.29%
TOTAL ASSETS
Total Short-Term Assets $1.578B $2.000M
Total Long-Term Assets $164.9M $230.0M
Total Assets $1.743B $232.0M
YoY Change 651.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $14.14M $300.0K
YoY Change 4611.67%
Accrued Expenses $10.78M $100.0K
YoY Change 10684.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $100.0K
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $25.27M $500.0K
YoY Change 4954.2%
LONG-TERM LIABILITIES
Long-Term Debt $38.71M $0.00
YoY Change
Other Long-Term Liabilities $171.0M $8.100M
YoY Change 2010.75%
Total Long-Term Liabilities $209.7M $8.100M
YoY Change 2488.63%
TOTAL LIABILITIES
Total Short-Term Liabilities $25.27M $500.0K
Total Long-Term Liabilities $209.7M $8.100M
Total Liabilities $235.0M $8.500M
YoY Change 2664.12%
SHAREHOLDERS EQUITY
Retained Earnings -$1.972B
YoY Change
Common Stock $3.479B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.506B $123.8M $135.8M
YoY Change
Total Liabilities & Shareholders Equity $1.743B $232.0M
YoY Change 651.33%

Cashflow Statement

Concept 2021 Q2 2020 Q2 2020 Q1
OPERATING ACTIVITIES
Net Income $80.99M -$13.95M -$15.37M
YoY Change -680.77%
Depreciation, Depletion And Amortization $3.520M $1.442M
YoY Change
Cash From Operating Activities -$32.90M -$27.61K -$11.48M
YoY Change 119037.3%
INVESTING ACTIVITIES
Capital Expenditures -$30.39M $4.934M
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$398.0M -$230.0M
YoY Change 73.04%
Cash From Investing Activities -$428.4M -$230.0M $27.07M
YoY Change 86.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $25.00K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 110.8M 231.8M 13.00K
YoY Change -52.18%
NET CHANGE
Cash From Operating Activities -32.90M -27.61K -11.48M
Cash From Investing Activities -428.4M -230.0M 27.07M
Cash From Financing Activities 110.8M 231.8M 13.00K
Net Change In Cash -350.4M 1.740M 15.60M
YoY Change -20244.08%
FREE CASH FLOW
Cash From Operating Activities -$32.90M -$27.61K -$11.48M
Capital Expenditures -$30.39M $4.934M
Free Cash Flow -$2.510M -$16.42M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
239795000
qs Change In Fair Value Of Assumed Common Stock Warrant Liabilities
ChangeInFairValueOfAssumedCommonStockWarrantLiabilities
-99740000
CY2021Q2 us-gaap Lessee Finance Lease Existence Of Option To Extend
LesseeFinanceLeaseExistenceOfOptionToExtend
true
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P11Y3M18D
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P11Y1M6D
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y7M6D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y9M7D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y9M10D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y18D
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P5Y9M10D
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
29900000
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
349000
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-694000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-31000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1971730000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1977639000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1506431000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2021Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
38105000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11712000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2193000
CY2020Q4 us-gaap Assets
Assets
1066769000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5383000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2701000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2391000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1220000
CY2020Q4 qs Strategic Premium Short Term Liability Current
StrategicPremiumShortTermLiabilityCurrent
655000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12350000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11244000
CY2021Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
38708000
CY2021Q2 qs Assumed Common Stock Warrant Liabilities Noncurrent
AssumedCommonStockWarrantLiabilitiesNoncurrent
148455000
CY2020Q4 qs Assumed Common Stock Warrant Liabilities Noncurrent
AssumedCommonStockWarrantLiabilitiesNoncurrent
689699000
CY2021Q2 us-gaap Liabilities
Liabilities
234950000
CY2020Q4 us-gaap Liabilities
Liabilities
713293000
CY2021Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1694000
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1704000
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1250000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1250000000
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
41000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
36000
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3478814000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2329406000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
100196000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
819000
CY2020Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
351772000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1743075000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1066769000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
35776000
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12049000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-10000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-5000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-49622000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
80988000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-13945000
us-gaap Net Income Loss
NetIncomeLoss
5909000
us-gaap Net Income Loss
NetIncomeLoss
-29319000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
29056000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4747000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
49622000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
14227000
us-gaap Operating Expenses
OperatingExpenses
94297000
us-gaap Operating Expenses
OperatingExpenses
30143000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-14227000
us-gaap Operating Income Loss
OperatingIncomeLoss
-94297000
us-gaap Operating Income Loss
OperatingIncomeLoss
-30143000
CY2021Q2 us-gaap Interest Expense
InterestExpense
238000
us-gaap Interest Expense
InterestExpense
238000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
80988000
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-13946000
us-gaap Profit Loss
ProfitLoss
5899000
us-gaap Profit Loss
ProfitLoss
-29324000
CY2021Q2 qs Net Income Loss Tax Portion Attributable To Noncontrolling Interest
NetIncomeLossTaxPortionAttributableToNoncontrollingInterest
0
qs Net Income Loss Tax Portion Attributable To Noncontrolling Interest
NetIncomeLossTaxPortionAttributableToNoncontrollingInterest
0
CY2020Q2 qs Net Income Loss Tax Portion Attributable To Noncontrolling Interest
NetIncomeLossTaxPortionAttributableToNoncontrollingInterest
0
qs Net Income Loss Tax Portion Attributable To Noncontrolling Interest
NetIncomeLossTaxPortionAttributableToNoncontrollingInterest
0
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
281000
us-gaap Investment Income Interest
InvestmentIncomeInterest
596000
us-gaap Investment Income Interest
InvestmentIncomeInterest
819000
CY2021Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-130504000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-99740000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
98000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
130610000
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
281000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
80988000
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-13946000
us-gaap Profit Loss
ProfitLoss
5899000
us-gaap Profit Loss
ProfitLoss
-29324000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-837000
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-258000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-663000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
57000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
80151000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-14204000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
5236000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-29267000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-10000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-5000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
80151000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14203000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5246000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-29262000
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
404957000
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
239798000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
386970000
CY2021Q2 qs Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
12265000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11607000
CY2020Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1706000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
135843000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2185000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
410372000
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
239798000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
396059000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
239795000
CY2021Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1694000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1293906000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8572000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
80988000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-837000
CY2021Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1694000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1506431000
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1704000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
351772000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9452000
qs Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
553822000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
23283000
us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
-10000
us-gaap Net Income Loss
NetIncomeLoss
5909000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-663000
CY2021Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1694000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1506431000
CY2020Q2 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
-1000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-13945000
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-258000
CY2020Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1705000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
123826000
CY2019Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1710000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
148692000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
14000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4382000
us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
-5000
us-gaap Net Income Loss
NetIncomeLoss
-29319000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
57000
us-gaap Share Based Compensation
ShareBasedCompensation
4382000
CY2020Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1705000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
123826000
us-gaap Profit Loss
ProfitLoss
5899000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
462926000
qs Proceeds From Issuance Of Class A Common Stock Pursuant To Legacy Quantum Scape Series F Preferred Stock Purchase Agreement Net Of Issuance Costs
ProceedsFromIssuanceOfClassACommonStockPursuantToLegacyQuantumScapeSeriesFPreferredStockPurchaseAgreementNetOfIssuanceCosts
99930000
us-gaap Profit Loss
ProfitLoss
-29324000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5155000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3075000
qs Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
706000
qs Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
605000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
565000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-5432000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
5000
qs Amortization Of Strategic Premium
AmortizationOfStrategicPremium
302000
qs Amortization Of Strategic Premium
AmortizationOfStrategicPremium
327000
us-gaap Share Based Compensation
ShareBasedCompensation
23283000
qs Proceeds From Finance Lease Net Of Principal Payment
ProceedsFromFinanceLeaseNetOfPrincipalPayment
38000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
683648000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14000
qs Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-804000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
113000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
8000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-468000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
448000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5016000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
579000
qs Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-529000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-54435000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
43655000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9891000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
411000000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
62000000
qs Proceeds From Sales Of Marketable Securities
ProceedsFromSalesOfMarketableSecurities
121455000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
819339000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
24351000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-330539000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
27758000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
9452000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
14000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
112318000
qs Payment Of Business Combination Share Issuance Costs
PaymentOfBusinessCombinationShareIssuanceCosts
1016000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
298674000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5772000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
115410000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
25596000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
414084000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
31368000
us-gaap Interest Paid Net
InterestPaidNet
238000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
13090000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1524000
qs Fair Value Of Assumed Common Stock Warrants Exercised
FairValueOfAssumedCommonStockWarrantsExercised
441504000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
402391000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29175000
CY2021Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
11693000
CY2020Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2193000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
414084000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
31368000
CY2021Q2 qs Goodwill Or Other Intangible Assets
GoodwillOrOtherIntangibleAssets
0
CY2021Q2 us-gaap Marketable Securities
MarketableSecurities
94500000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the condensed consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of commitments and contingencies at the date of the financial statements as well as reported amounts of expenses during the reporting periods. Estimates made by the Company include, but are not limited to, those related to the valuation of common stock prior to the Business Combination, valuation of convertible preferred stock warrants, valuation of convertible preferred stock tranche liabilities, and valuation of assumed common stock warrants among others. The Company bases these estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from those estimates. </p>
CY2018Q3 qs Number Of Operating Agreements Of Joint Venture Parties
NumberOfOperatingAgreementsOfJointVentureParties
2
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Concentrations of Credit Risk </p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to credit risk consist principally of cash and cash equivalents and marketable securities. As of June 30, 2021 and December 31, 2020, approximately $302.8 million and $12.2 million of our total cash and cash equivalents and marketable securities, are held in U.S. money market funds, and $789.4 million and $977.3 million are invested in U.S. government and agency securities, respectively. The Company seeks to mitigate its credit risk with respect to cash and cash equivalents and marketable securities by making deposits with large, reputable financial institutions and investing in high credit rated shorter-term instruments. </p>
CY2021Q2 us-gaap Restricted Cash
RestrictedCash
11700000
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
2200000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
0
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q2 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2020Q2 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2021Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2020Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
0
us-gaap Business Acquisition Effective Date Of Acquisition1
BusinessAcquisitionEffectiveDateOfAcquisition1
2020-11-25
us-gaap Business Acquisition Date Of Acquisition Agreement1
BusinessAcquisitionDateOfAcquisitionAgreement1
2020-09-02
CY2020Q4 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
1350000000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
us-gaap Common Stock Voting Rights
CommonStockVotingRights
The holder of each share of Class A Common Stock is entitled to one vote, and the holder of each share of Class B Common Stock is entitled to ten votes.
CY2021Q2 qs Finance Lease Liability Payments Net Of Reimbursements Due
FinanceLeaseLiabilityPaymentsNetOfReimbursementsDue
50223000
CY2021Q2 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
349922000
CY2021Q2 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
349227000
CY2020Q4 us-gaap Marketable Securities
MarketableSecurities
105200000
qs Number Of Marketable Securities
NumberOfMarketableSecurities
81
CY2020 qs Number Of Marketable Securities
NumberOfMarketableSecurities
12
qs Marketable Securities In Unrealized Loss Position
MarketableSecuritiesInUnrealizedLossPosition
616900000
CY2020 qs Marketable Securities In Unrealized Loss Position
MarketableSecuritiesInUnrealizedLossPosition
419200000
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
122300000
CY2021Q2 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
122300000
CY2020Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2021Q2 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
1213212000
CY2021Q2 us-gaap Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
1213213000
CY2020Q4 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
895867000
CY2020Q4 us-gaap Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
895830000
CY2020Q4 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
93725000
CY2020Q4 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
93731000
CY2021Q2 us-gaap Held To Maturity Securities Debt Maturities Single Maturity Date Amortized Cost Basis
HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
1563134000
CY2021Q2 us-gaap Held To Maturity Securities Debt Maturities Single Maturity Date Fair Value
HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue
1562440000
CY2020Q4 us-gaap Held To Maturity Securities Debt Maturities Single Maturity Date Amortized Cost Basis
HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
989592000
CY2020Q4 us-gaap Held To Maturity Securities Debt Maturities Single Maturity Date Fair Value
HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue
989561000
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
128062000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
76006000
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
36845000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
32310000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
91217000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
43696000
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
5865000
qs Lessee Operating Lease Expiration Year
LesseeOperatingLeaseExpirationYear
2032
us-gaap Lease Cost
LeaseCost
1273000
CY2021Q2 qs Depreciation And Amortization Of Property And Equipment
DepreciationAndAmortizationOfPropertyAndEquipment
3000000.0
CY2020Q2 qs Depreciation And Amortization Of Property And Equipment
DepreciationAndAmortizationOfPropertyAndEquipment
1600000
qs Depreciation And Amortization Of Property And Equipment
DepreciationAndAmortizationOfPropertyAndEquipment
5200000
qs Depreciation And Amortization Of Property And Equipment
DepreciationAndAmortizationOfPropertyAndEquipment
3100000
CY2021Q2 qs Lessee Operating Lease Extension Of Lease Term Month And Year
LesseeOperatingLeaseExtensionOfLeaseTermMonthAndYear
2032-09
CY2021Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P60M
CY2021Q2 qs Area Of Rentable Space Lease
AreaOfRentableSpaceLease
197000
CY2021Q2 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2032-09-30
CY2021Q2 qs Number Of Finance Lease Renewal Options
NumberOfFinanceLeaseRenewalOptions
2
CY2021Q2 us-gaap Lessee Finance Lease Renewal Term1
LesseeFinanceLeaseRenewalTerm1
P5Y
CY2021Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
565000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
565000
CY2021Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
238000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
238000
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
629000
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
536000
us-gaap Operating Lease Cost
OperatingLeaseCost
1225000
us-gaap Operating Lease Cost
OperatingLeaseCost
1072000
CY2021Q2 us-gaap Variable Lease Cost
VariableLeaseCost
114000
CY2020Q2 us-gaap Variable Lease Cost
VariableLeaseCost
97000
us-gaap Variable Lease Cost
VariableLeaseCost
218000
us-gaap Variable Lease Cost
VariableLeaseCost
201000
CY2021Q2 us-gaap Lease Cost
LeaseCost
1546000
CY2020Q2 us-gaap Lease Cost
LeaseCost
633000
us-gaap Lease Cost
LeaseCost
2246000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
238000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
166000
qs Proceeds From Finance Lease
ProceedsFromFinanceLease
204000
us-gaap Operating Lease Payments
OperatingLeasePayments
985000
us-gaap Operating Lease Payments
OperatingLeasePayments
995000
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
38670000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
11686000
CY2021Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0370
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0373
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0700
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1178000
CY2021Q2 qs Finance Lease Liability Payments Net Of Reimbursements Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsNetOfReimbursementsRemainderOfFiscalYear
-5397000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2423000
CY2021Q2 qs Finance Lease Liability Payments Net Of Reimbursements Due Next Twelve Months
FinanceLeaseLiabilityPaymentsNetOfReimbursementsDueNextTwelveMonths
2419000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1344000
CY2021Q2 qs Finance Lease Liability Payments Net Of Reimbursements Due Year Two
FinanceLeaseLiabilityPaymentsNetOfReimbursementsDueYearTwo
3750000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2588000
CY2021Q2 qs Finance Lease Liability Payments Net Of Reimbursements Due Year Three
FinanceLeaseLiabilityPaymentsNetOfReimbursementsDueYearThree
5130000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2639000
CY2021Q2 qs Finance Lease Liability Payments Net Of Reimbursements Due Year Four
FinanceLeaseLiabilityPaymentsNetOfReimbursementsDueYearFour
5272000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
2718000
CY2021Q2 qs Finance Lease Liability Payments Net Of Reimbursements Due Year Five
FinanceLeaseLiabilityPaymentsNetOfReimbursementsDueYearFive
5417000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
17010000
CY2021Q2 qs Finance Lease Liability Payments Net Of Reimbursements Due After Year Five
FinanceLeaseLiabilityPaymentsNetOfReimbursementsDueAfterYearFive
33632000
CY2021Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
11515000
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
24035000
CY2021Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
38708000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
34715518
CY2021Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
8288965
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
44420560
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.78
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1220577000
CY2021Q2 qs Expected Reimbursements For Tenant Improvement Allowance
ExpectedReimbursementsForTenantImprovementAllowance
5400000
CY2021Q1 qs Number Of Shareholder Derivative Suit Filed
NumberOfShareholderDerivativeSuitFiled
2
CY2021Q1 qs Number Of Officers And Directors In Shareholder Derivative Suit
NumberOfOfficersAndDirectorsInShareholderDerivativeSuit
11
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
18149989
CY2021Q2 qs Change In Fair Value Of Assumed Common Stock Warrant Liabilities
ChangeInFairValueOfAssumedCommonStockWarrantLiabilities
-130500000
qs Change In Fair Value Of Assumed Common Stock Warrant Liabilities
ChangeInFairValueOfAssumedCommonStockWarrantLiabilities
-99700000
CY2021Q2 qs Shares Authorized
SharesAuthorized
1350000000
CY2020Q4 qs Shares Authorized
SharesAuthorized
1350000000
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
us-gaap Common Stock Voting Rights
CommonStockVotingRights
The holder of each share of Class A Common Stock is entitled to one vote, and the holder of each share of Class B Common Stock is entitled to ten votes.
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
55316336
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.62
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
366724
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.34
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
10529052
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.90
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.33
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
969562000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
qs Share Based Compensation Arrangement By Share Based Payment Award Options Grated In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGratedInPeriodFairValue
2800000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.38
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
330000000.0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
40000.00
CY2021Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
44420560
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.78
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
17000000.0
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y9M18D
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-5000
CY2020Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1705000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11607000
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2185000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
23283000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4382000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
80988000
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13945000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5909000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-29319000
CY2021Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-130504000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-99740000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-49516000
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-13945000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-93831000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-29319000
CY2021Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
5415000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
9089000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
55744000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
56042000
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1704000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-10000
CY2021Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1694000
CY2019Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
1710000

Files In Submission

Name View Source Status
0001564590-21-039145-index-headers.html Edgar Link pending
0001564590-21-039145-index.html Edgar Link pending
0001564590-21-039145.txt Edgar Link pending
0001564590-21-039145-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
qs-10q_20210630.htm Edgar Link pending
qs-10q_20210630_htm.xml Edgar Link completed
qs-20210630.xsd Edgar Link pending
qs-20210630_cal.xml Edgar Link unprocessable
qs-20210630_def.xml Edgar Link unprocessable
qs-20210630_lab.xml Edgar Link unprocessable
qs-20210630_pre.xml Edgar Link unprocessable
qs-ex311_7.htm Edgar Link pending
qs-ex312_8.htm Edgar Link pending
qs-ex321_6.htm Edgar Link pending
qs-ex322_9.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending